Get the Stockscreener App
4.62
0.86%
-0.04
After Hours:
4.96
0.34
+7.36%
Organogenesis Holdings Inc stock is traded at $4.62, with a volume of 439.26K.
It is down -0.86% in the last 24 hours and up +26.23% over the past month.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
See More
Previous Close:
$4.66
Open:
$4.62
24h Volume:
439.26K
Relative Volume:
0.37
Market Cap:
$586.06M
Revenue:
$433.14M
Net Income/Loss:
$4.95M
P/E Ratio:
129.41
EPS:
0.0357
Net Cash Flow:
$6.55M
1W Performance:
-2.74%
1M Performance:
+26.23%
6M Performance:
+25.54%
1Y Performance:
+52.98%
1-Day Range:
$4.575
$4.72
1-Week Range:
$4.575
$5.148
52-Week Range:
$2.28
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
Name
Organogenesis Holdings Inc
Sector
Phone
781-575-0775
Address
85 DAN ROAD, CANTON, MA
Compare ORGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.62 | 591.14M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Lake Street | Buy |
| Feb-07-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-15-23 | Initiated | Morgan Stanley | Equal-Weight |
| May-24-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-10-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-10-20 | Initiated | SVB Leerink | Outperform |
| Aug-26-19 | Resumed | Credit Suisse | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
| Apr-17-19 | Initiated | Oppenheimer | Outperform |
| Apr-11-19 | Initiated | SunTrust | Buy |
View All
Organogenesis Holdings Inc Stock (ORGO) Latest News
Will a bounce in Organogenesis Holdings Inc. offer an exitTrend Reversal Probability Forecast Update - Newser
Market reaction to Organogenesis Holdings Inc.’s recent newsFree Consistent Profit Pattern Recognition Tools - Newser
What analysts say about Organogenesis Holdings Inc. stock outlookEntry Opportunity Screener with Confirmation - Newser
What catalysts could drive Organogenesis Holdings Inc. stock higher in 2025Top Growth Alerts Backed By Experts - jammulinksnews.com
What makes Organogenesis Holdings Inc. stock price move sharplyFree Stock Target Finder With Proven Results - jammulinksnews.com
Should I hold or sell Organogenesis Holdings Inc. stock in 2025Expert Picks Outlook To Watch Now - jammulinksnews.com
Why is Organogenesis Holdings Inc. stock attracting strong analyst attentionStock Market Opportunities For Every Investor - jammulinksnews.com
Is Organogenesis Holdings Inc. stock overvalued or undervaluedSwing Trade Report To Watch Now - jammulinksnews.com
Can you recover from losses in Organogenesis Holdings Inc.Watchlist Generator With Real-Time Entry - Newser
Is Organogenesis Holdings Inc. stock entering bullish territoryDay Trading Setup and Momentum Analysis - Newser
Applying Elliott Wave Theory to Organogenesis Holdings Inc.High Yield Watchlist with Filtered Picks - Newser
What technical models suggest about Organogenesis Holdings Inc.’s comebackHistorical Stock Summary and ROI Review - Newser
Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Moving Average Trends for Organogenesis Holdings Inc. Stock: What They IndicateWeekly High Conviction Trade Setup Analysis - Newser
Organogenesis Holdings Inc. Tests 50 Day MA After Sharp DeclineEarly Entry Picks Before News Breakout Reviewed - metal.it
How Organogenesis Holdings Inc. stock performs during market volatilityFree Entry Zone Strategy for Consistent Profit - Newser
How did ORGO's revenue and expenses shift in Q4 2024? - AInvest
Organogenesis Holdings Inc. Stock Support and Resistance Levels You Should KnowCommunity Picked Stocks with Trade Insights - Newser
Organogenesis Holdings Inc. Shows Risk Reward Favoring UpsideBreakout Confirmation With Entry Tracker Enabled - metal.it
Published on: 2025-07-28 21:16:52 - metal.it
What is the dividend policy of Organogenesis Holdings Inc. stockBeginner Investor Alerts For Fast Growth - jammulinksnews.com
When is Organogenesis Holdings Inc. stock expected to show significant growthCapitalize on fast-growing stocks today - jammulinksnews.com
Cerity Partners LLC Raises Stake in Organogenesis (NASDAQ:ORGO) - Defense World
Intraday pattern recognizer results for Organogenesis Holdings Inc. Deep Stock Performance and Volatility Analysis - Newser
What is Organogenesis Holdings Inc. company’s growth strategyUnlock expert stock analysis and alerts - jammulinksnews.com
What institutional investors are buying Organogenesis Holdings Inc. stockFree Investment Community - jammulinksnews.com
Cwm LLC Has $276,000 Holdings in Organogenesis (NASDAQ:ORGO) - Defense World
Why Organogenesis Holdings Inc. stock attracts strong analyst attentionReal Chart Play - Newser
What analysts say about Organogenesis Holdings Inc. stockFree Stock Index Interpretation - PrintWeekIndia
Organogenesis Holdings Inc. Stock Analysis and ForecastExceptional growth trajectory - PrintWeekIndia
Is Organogenesis Holdings Inc. stock a growth or value playFree Stock Market Mentorship - jammulinksnews.com
What drives Organogenesis Holdings Inc. stock priceExceptional growth trajectory - Autocar Professional
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm - ACCESS Newswire
Discovering Opportunities: 3 Penny Stocks With Market Caps Over $200M - simplywall.st
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2025 Financial Results on August 7, 2025 - The Manila Times
Is Organogenesis Holdings Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com
Organogenesis Holdings Inc Stock (ORGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):